Difference between revisions of "Prostatic specific acid phosphatase"

From Libre Pathology
Jump to navigation Jump to search
 
(4 intermediate revisions by the same user not shown)
Line 1: Line 1:
'''Prostatic specific acid phosphatase''', abbreviated '''PSAP''', is [[prostate gland|prostate]] marker that predated [[prostate specific antigen|PSA]].
'''Prostatic specific acid phosphatase''', abbreviated '''PSAP''', is [[prostate gland|prostate]] marker that predated [[prostate-specific antigen]] (PSA).
 
It is also known as '''prostatic acid phosphatase''', abbreviated '''PAP'''.


==General==
==General==
*Cannot differentiate between benign prostate and [[prostate cancer]], like PSA.<ref name=pmid9428385>{{Cite journal  | last1 = Sauvageot | first1 = J. | last2 = Epstein | first2 = JI. | title = Immunoreactivity for prostate-specific antigen and prostatic acid phosphatase in adenocarcinoma of the prostate: relation to progression following radical prostatectomy. | journal = Prostate | volume = 34 | issue = 1 | pages = 29-33 | month = Jan | year = 1998 | doi =  | PMID = 9428385 }}</ref>
*Cannot differentiate between benign prostate and [[prostate cancer]], like PSA.<ref name=pmid9428385>{{Cite journal  | last1 = Sauvageot | first1 = J. | last2 = Epstein | first2 = JI. | title = Immunoreactivity for prostate-specific antigen and prostatic acid phosphatase in adenocarcinoma of the prostate: relation to progression following radical prostatectomy. | journal = Prostate | volume = 34 | issue = 1 | pages = 29-33 | month = Jan | year = 1998 | doi =  | PMID = 9428385 }}</ref>
===Positive===
*Benign prostate.
*[[Prostate cancer]].
*Some hindgut [[neuroendocrine tumour]]s.<ref name=pmid1712549>{{Cite journal  | last1 = Azumi | first1 = N. | last2 = Traweek | first2 = ST. | last3 = Battifora | first3 = H. | title = Prostatic acid phosphatase in carcinoid tumors. Immunohistochemical and immunoblot studies. | journal = Am J Surg Pathol | volume = 15 | issue = 8 | pages = 785-90 | month = Aug | year = 1991 | doi =  | PMID = 1712549 }}</ref><ref>{{cite journal |authors=Koo J, Zhou X, Moschiano E, De Peralta-Venturina M, Mertens RB, Dhall D |title=The immunohistochemical expression of islet 1 and PAX8 by rectal neuroendocrine tumors should be taken into account in the differential diagnosis of metastatic neuroendocrine tumors of unknown primary origin |journal=Endocr Pathol |volume=24 |issue=4 |pages=184–90 |date=December 2013 |pmid=24037217 |doi=10.1007/s12022-013-9264-9 |url=}}</ref>


==Microscopic==
==Microscopic==
Line 10: Line 17:
===Images===
===Images===
<gallery>
<gallery>
Image:Prostate carcinoma in rectum - PSAP -- intermed mag.jpg | PSAP - intermed. mag.
Image:Prostate carcinoma in rectum - PSAP -- high mag.jpg | PSAP - high mag.
Image:Prostate carcinoma in rectum - PSAP -- high mag.jpg | PSAP - high mag.
Image:Prostate carcinoma in rectum - PSAP -- very high mag.jpg | PSAP - very high mag.
</gallery>
</gallery>



Latest revision as of 20:55, 2 August 2022

Prostatic specific acid phosphatase, abbreviated PSAP, is prostate marker that predated prostate-specific antigen (PSA).

It is also known as prostatic acid phosphatase, abbreviated PAP.

General

Positive

Microscopic

Features:

  • Cytoplasmic staining.

Images

References

  1. Sauvageot, J.; Epstein, JI. (Jan 1998). "Immunoreactivity for prostate-specific antigen and prostatic acid phosphatase in adenocarcinoma of the prostate: relation to progression following radical prostatectomy.". Prostate 34 (1): 29-33. PMID 9428385.
  2. Azumi, N.; Traweek, ST.; Battifora, H. (Aug 1991). "Prostatic acid phosphatase in carcinoid tumors. Immunohistochemical and immunoblot studies.". Am J Surg Pathol 15 (8): 785-90. PMID 1712549.
  3. Koo J, Zhou X, Moschiano E, De Peralta-Venturina M, Mertens RB, Dhall D (December 2013). "The immunohistochemical expression of islet 1 and PAX8 by rectal neuroendocrine tumors should be taken into account in the differential diagnosis of metastatic neuroendocrine tumors of unknown primary origin". Endocr Pathol 24 (4): 184–90. doi:10.1007/s12022-013-9264-9. PMID 24037217.